🔎 Trials Near Me

Home › Non-Small Cell Lung Cancer › Connecticut › Hartford

Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa Hartford, CT

Isang pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Hartford. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Nagre-recruitPhase 3
  • Smilow Cancer Hospital Care Center at Saint Francis, Hartford
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT04267848

A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)

Nagre-recruitPhase 3
  • University of Connecticut Health Center ( Site 0130), Farmington · 8 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07190248

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Nagre-recruitPhase 3
  • Hartford Hospital, Hartford
  • Hartford HealthCare - Avon, Avon · 8 mi ang layo
  • Hartford HealthCare - Manchester, Manchester · 8 mi ang layo
  • at 1 pa
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06498635

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Nagre-recruitPhase 3
  • Hartford Hospital (HH), Hartford
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06890598

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Nagre-recruitPhase 2
  • Smilow Cancer Hospital Care Center at Saint Francis, Hartford
  • Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 3, 2026 · NCT05642572

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Nagre-recruitPhase 2/3
  • Smilow Cancer Hospital Care Center at Saint Francis, Hartford
  • Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update May 5, 2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Nagre-recruitPhase 2
  • Smilow Cancer Hospital Care Center at Saint Francis, Hartford
  • Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury · 5 mi ang layo
18 Minutes · Lahat ng kasarian · Na-update May 5, 2026 · NCT06031688

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

Nagre-recruitPhase 2
  • Hartford Healthcare, Hartford
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 27, 2026 · NCT03808337

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Nagre-recruitPhase 1/2
  • Hartford Hospital (site 210), Hartford
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Dis 11, 2025 · NCT03556228

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral
  • Massive Bio SYNERGY-AI site, Hartford
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod

Iba pang pag-aaral sa Hartford

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.